Quantum X Labs Inc. QXL
5.00
(0.17)
(3.29%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 34.2×
Follow QXL
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 38.93 |
P/S ratio |
0.00 | 8.26 | 16.43 | 61.90 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(16.19) | (59.47) | (37.89) | (76.71) | |
P/B ratio |
6.32 | 2.60 | 1.06 | 3.16 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 29.48 | |
EV/Sales |
(2.53) | 9.19 | 16.76 | 61.46 | |
EV/EBITDA |
11.00 | 0.00 | 0.00 | 48.38 | |
EV/Operating CF |
(12.10) | (5.21) | (6.55) | (19.51) | |
EV/FCF |
(12.04) | (5.18) | (6.52) | (18.64) | |
Quick Ratio |
0.43 | 0.33 | 0.59 | 0.77 | |
Current Ratio |
0.48 | 0.41 | 0.68 | 0.86 | |
Net Debt/EBITDA |
0.37 | (0.33) | (1.43) | (0.22) | |
Debt/Assets |
22.22% | 23.18% | 8.32% | 6.11% | |
Debt/Equity |
0.65 | 0.50 | 0.11 | 0.07 | |
Asset Turnover |
(0.63) | 0.10 | 0.05 | 0.05 | |
Operating CF/Net income |
0.67 | 0.39 | 1.00 | (0.43) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.82) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.23% | 4.01% | 0.00% | 63.14% | |
Selling, General and Administrative Expense of Revenue |
29.15% | (6.25%) | 148.73% | 355.29% | |
Intangible Assets out of Total Assets |
0.75 | 0.78 | 0.87 | 0.74 | |
Share Based Compensation of Revenue |
0.11% | 0.15% | 0.00% | 0.00% | |
Graham Net Nets |
(0.19) | (0.32) | (0.14) | (0.02) | |
Graham Number |
0.00 | 0.00 | 0.00 | 2.44 | |
Earnings Yield |
(89.78%) | (147.95%) | (82.09%) | 2.57% | |
Free Cash Flow Yield |
(8.62%) | (21.47%) | (15.64%) | (5.33%) | |
Revenue per Share |
0.26 | (0.24) | 0.03 | 0.02 | |
Operating CF per Share |
(0.22) | (0.03) | (0.05) | (0.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.22) | (0.03) | (0.05) | (0.09) | |
Cash per Share |
0.23 | 0.12 | 0.16 | 0.17 | |
Shareholders Equity per Share |
0.55 | 0.59 | 1.89 | 1.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.55 | 0.59 | 1.89 | 1.80 | |
Free Cash Flow |
(2.26) | (0.22) | (0.60) | (1.25) | |
Working Capital |
(4.45) | (2.41) | (1.35) | (0.55) | |
Capital Expenditures |
— | — | — | (0.19) | |
Net Current Asset Value |
(6.98) | (4.12) | (3.13) | (1.89) | |
EV/EBIT |
20.57 | 0.00 | 0.00 | 103.70 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.63 | |
Net Profit Margin |
(124.88%) | 27.65% | (171.39%) | 848.12% | |
Price to Operating Income |
19.82 | 0.00 | 0.00 | 104.44 | |
| Other line items | |||||
Average Receivables |
3.71 | 0.44 | 0.86 | 0.83 | |
Average Payables |
7.35 | 1.82 | 3.03 | 3.34 | |
Average Assets |
23.84 | 16.36 | 27.06 | 25.63 | |
Average Common Equity |
8.68 | 6.25 | 15.26 | 15.55 |
Columns are period end dates